NO931141L - Tnf-muteiner - Google Patents
Tnf-muteinerInfo
- Publication number
- NO931141L NO931141L NO93931141A NO931141A NO931141L NO 931141 L NO931141 L NO 931141L NO 93931141 A NO93931141 A NO 93931141A NO 931141 A NO931141 A NO 931141A NO 931141 L NO931141 L NO 931141L
- Authority
- NO
- Norway
- Prior art keywords
- mutein
- necrosis factor
- tumor necrosis
- vector
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92810249 | 1992-04-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO931141D0 NO931141D0 (no) | 1993-03-26 |
NO931141L true NO931141L (no) | 1993-10-04 |
Family
ID=8211902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93931141A NO931141L (no) | 1992-04-02 | 1993-03-26 | Tnf-muteiner |
Country Status (19)
Country | Link |
---|---|
US (1) | US5486463A (sl) |
EP (1) | EP0563714A3 (sl) |
JP (1) | JPH07285997A (sl) |
CN (1) | CN1037844C (sl) |
AU (1) | AU659927B2 (sl) |
BR (1) | BR9301420A (sl) |
CA (1) | CA2091313A1 (sl) |
CZ (1) | CZ283533B6 (sl) |
FI (1) | FI931488A (sl) |
HU (1) | HUT69790A (sl) |
IL (1) | IL105170A0 (sl) |
MX (1) | MX9301700A (sl) |
NO (1) | NO931141L (sl) |
NZ (1) | NZ247265A (sl) |
PL (1) | PL298345A1 (sl) |
SK (1) | SK376492A3 (sl) |
TW (1) | TW260707B (sl) |
UY (1) | UY23561A1 (sl) |
ZA (1) | ZA932177B (sl) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR970005042B1 (ko) * | 1993-02-09 | 1997-04-11 | 한일합성섬유공업 주식회사 | 종양괴사인자-알파 뮤테인 |
CA2119089A1 (en) * | 1993-03-29 | 1994-09-30 | David Banner | Tumor necrosis factor muteins |
CN1049663C (zh) * | 1994-09-01 | 2000-02-23 | 中国科学院上海生物工程研究中心 | 突变的人肿瘤坏死因子 |
US7070771B1 (en) | 1996-12-09 | 2006-07-04 | Regents Of The University Of California | Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells |
US20020077276A1 (en) * | 1999-04-27 | 2002-06-20 | Fredeking Terry M. | Compositions and methods for treating hemorrhagic virus infections and other disorders |
US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
ATE329610T1 (de) * | 2000-02-16 | 2006-07-15 | Genentech Inc | Anti-april antikörper und hybridomazellen |
HUP0500992A3 (en) * | 2001-08-03 | 2007-11-28 | Genentech Inc | Tacis and br3 polypeptides and uses thereof |
US7786282B2 (en) * | 2001-12-06 | 2010-08-31 | The Regents Of The University Of California | Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain |
US20030199024A1 (en) * | 2002-04-19 | 2003-10-23 | Hansen Ted H. | Single chain trimers of class I MHC molecules |
JP2005533863A (ja) * | 2002-07-25 | 2005-11-10 | ジェネンテック・インコーポレーテッド | Taci抗体とその用途 |
CA2508375C (en) * | 2002-12-02 | 2014-05-27 | Abgenix, Inc. | Antibodies directed to tumor necrosis factor and uses thereof |
US20040121971A1 (en) * | 2002-12-20 | 2004-06-24 | Gang Chen | Therapeutic use of tumor necrosis factor-alpha mutein |
US20050163775A1 (en) * | 2003-06-05 | 2005-07-28 | Genentech, Inc. | Combination therapy for B cell disorders |
PT2272868E (pt) * | 2003-06-05 | 2015-07-07 | Genentech Inc | Terapêutica de combinação para distúrbios de células b |
CN100390200C (zh) * | 2003-11-24 | 2008-05-28 | 中国医学科学院基础医学研究所 | 一种用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白 |
TW200526780A (en) * | 2004-01-06 | 2005-08-16 | Hayashibara Biochem Lab | TNF antagonists and TNF inhibitors comprising the same as the active ingredient |
CN1752211B (zh) * | 2004-09-23 | 2010-09-15 | 中国医学科学院基础医学研究所 | 用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白 |
GB0425972D0 (en) | 2004-11-25 | 2004-12-29 | Celltech R&D Ltd | Biological products |
US7850960B2 (en) | 2004-12-30 | 2010-12-14 | University Of Washington | Methods for regulation of stem cells |
US20070065514A1 (en) * | 2005-09-22 | 2007-03-22 | Howell Mark D | Method for enhancing immune responses in mammals |
CA2629306A1 (en) * | 2005-11-23 | 2007-05-31 | Genentech, Inc. | Methods and compositions related to b cell assays |
US8518697B2 (en) * | 2006-04-04 | 2013-08-27 | Washington University | Single chain trimers and uses therefor |
US20100316626A1 (en) * | 2006-08-11 | 2010-12-16 | The Government Of The United States Of America As Represented By The Secretary | Methods for treatment and diagnosis of psychiatric disorders |
WO2008127515A1 (en) * | 2007-03-01 | 2008-10-23 | Cytologic, Inc. | Compositions and method for enhancing immune responses in mammals |
DK2953634T3 (da) | 2013-02-07 | 2021-08-30 | Massachusetts Gen Hospital | Fremgangsmåder til udvidelse eller udtømning af regulerende t-celler |
US11224858B1 (en) | 2020-10-01 | 2022-01-18 | Immunicom, Inc. | Reduced leaching of a ligand |
JP2023544347A (ja) | 2020-10-01 | 2023-10-23 | イミューニコム, インコーポレイテッド | リガンドの浸出の低減 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07106158B2 (ja) * | 1986-12-04 | 1995-11-15 | サントリー株式会社 | 抗腫瘍活性を有する新規ポリペプチドおよびその製造法 |
CA2055168A1 (en) * | 1990-11-21 | 1992-05-22 | Walter Fiers | Tnf-muteins |
-
1992
- 1992-12-18 CZ CS923764A patent/CZ283533B6/cs unknown
- 1992-12-18 SK SK3764-92A patent/SK376492A3/sk unknown
-
1993
- 1993-02-25 TW TW082101370A patent/TW260707B/zh active
- 1993-03-09 CA CA002091313A patent/CA2091313A1/en not_active Abandoned
- 1993-03-20 EP EP19930104591 patent/EP0563714A3/en not_active Withdrawn
- 1993-03-24 HU HU9300843A patent/HUT69790A/hu unknown
- 1993-03-26 NZ NZ247265A patent/NZ247265A/en unknown
- 1993-03-26 MX MX9301700A patent/MX9301700A/es unknown
- 1993-03-26 ZA ZA932177A patent/ZA932177B/xx unknown
- 1993-03-26 IL IL105170A patent/IL105170A0/xx unknown
- 1993-03-26 NO NO93931141A patent/NO931141L/no unknown
- 1993-03-30 AU AU35611/93A patent/AU659927B2/en not_active Ceased
- 1993-03-31 UY UY23561A patent/UY23561A1/es unknown
- 1993-04-01 CN CN93103419A patent/CN1037844C/zh not_active Expired - Fee Related
- 1993-04-01 FI FI931488A patent/FI931488A/fi unknown
- 1993-04-01 JP JP5075445A patent/JPH07285997A/ja active Pending
- 1993-04-01 PL PL29834593A patent/PL298345A1/xx unknown
- 1993-04-01 US US08/041,648 patent/US5486463A/en not_active Expired - Fee Related
- 1993-04-02 BR BR9301420A patent/BR9301420A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US5486463A (en) | 1996-01-23 |
NO931141D0 (no) | 1993-03-26 |
NZ247265A (en) | 1995-10-26 |
SK376492A3 (en) | 1995-06-07 |
CN1079225A (zh) | 1993-12-08 |
HU9300843D0 (en) | 1993-06-28 |
JPH07285997A (ja) | 1995-10-31 |
CA2091313A1 (en) | 1993-10-03 |
AU659927B2 (en) | 1995-06-01 |
EP0563714A2 (en) | 1993-10-06 |
AU3561193A (en) | 1993-10-07 |
MX9301700A (es) | 1993-10-29 |
HUT69790A (en) | 1995-09-28 |
FI931488A0 (fi) | 1993-04-01 |
UY23561A1 (es) | 1993-09-20 |
BR9301420A (pt) | 1993-10-05 |
PL298345A1 (en) | 1993-12-27 |
IL105170A0 (en) | 1993-07-08 |
CN1037844C (zh) | 1998-03-25 |
CZ283533B6 (cs) | 1998-04-15 |
TW260707B (sl) | 1995-10-21 |
EP0563714A3 (en) | 1993-11-10 |
CZ376492A3 (en) | 1994-01-19 |
ZA932177B (en) | 1993-10-04 |
FI931488A (fi) | 1993-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO931141L (no) | Tnf-muteiner | |
NO914541L (no) | Fremgangsmaate ved fremstilling av tumor-nekrose-faktor-muteiner | |
Curry et al. | Calcium uptake by sarcoplasmic reticulum of muscle from vitamin D-deficient rabbits | |
DK305885D0 (da) | Tumornecrosefaktor og derivater og mutantformer deraf, frem. til frems. deraf, frem. til isolering deraf fra en blanding med andre proteiner,praeparater deraf, dna som koder derfor, dna'en inkorporeret i en replicerbar vektor og celle transformeret dermed | |
DK0559884T3 (da) | Rekombinante virusvektorer til ekspression i muskelceller | |
CA2223433A1 (en) | Ob protein compositions and methods | |
NO985975L (no) | Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav | |
AU1170588A (en) | Methods and deoxyribonucleic acid for the preparation of tissue factor protein | |
IT1252868B (it) | Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico | |
JO1365B1 (en) | Laoxy repo nucleic polypeptide acid has a physiological activity on humans and includes a basic sequence for the coded arrangement of the said polypeptide and a method for producing this for polypeptide and the pharmacological composition included. | |
DE69027865D1 (de) | ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN | |
NO963837D0 (no) | Nye muteiner av IFN- | |
CY1111912T1 (el) | Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων | |
KR960700062A (ko) | 산성 pH에서의 안정성을 개선시키기 위해 변형된 올리고누클레오티드(OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACIC pH) | |
ATE60759T1 (de) | Bisdimethoxymethyl(trimethoxybenzyl)isochinolinium salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
NZ279963A (en) | Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946 | |
CA2107552A1 (en) | Use of deprenyl to maintain, prevent loss, or recover nerve cell function | |
BR9912609A (pt) | Métodos de uso de um análogo de somatostatina | |
NO982935L (no) | Hyaluronsyre reseptor bindemiddel og anvendelse derav | |
CA2290739A1 (en) | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
EP0324447A3 (de) | Mittel und Verfahren zur Herstellung eines rekombinanten, menschlichen Interleukin-1 alpha-Polypeptides | |
RU93005356A (ru) | Tnf-мутеин | |
UA39179C2 (uk) | Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб | |
IE840977L (en) | Pharmaceutical preparations | |
CA2211413A1 (en) | Human dnase i variants |